Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Decreases By 41.9%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a large drop in short interest in the month of August. As of August 31st, there was short interest totaling 134,463 shares, a drop of 41.9% from the August 15th total of 231,413 shares. Approximately 0.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 130,940 shares, the days-to-cover ratio is currently 1.0 days.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

Several large investors have recently made changes to their positions in FTXH. Compass Financial Management LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the second quarter valued at approximately $29,000. Nilsine Partners LLC lifted its holdings in First Trust Nasdaq Pharmaceuticals ETF by 3.5% during the 2nd quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock worth $1,071,000 after buying an additional 937 shares in the last quarter. Vivaldi Capital Management LP lifted its holdings in First Trust Nasdaq Pharmaceuticals ETF by 16.0% during the 1st quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock worth $433,000 after buying an additional 1,741 shares in the last quarter. Flputnam Investment Management Co. bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter valued at $230,000. Finally, Marshall Investment Management LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter valued at $1,377,000.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.3%

FTXH stock traded up $0.14 during trading on Wednesday, hitting $40.83. The company had a trading volume of 29,748 shares, compared to its average volume of 220,345. The company has a fifty day moving average price of $40.09 and a two-hundred day moving average price of $36.71. The company has a market cap of $1.05 billion, a P/E ratio of 14.51 and a beta of 0.46. First Trust Nasdaq Pharmaceuticals ETF has a fifty-two week low of $27.30 and a fifty-two week high of $42.87.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Thursday, June 25th were paid a $0.092 dividend. The ex-dividend date was Thursday, June 25th. This represents a $0.37 annualized dividend and a dividend yield of 0.9%. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.